127 related articles for article (PubMed ID: 26845942)
1. [Development status of DAA against hepatitis C].
Kato N; Nakagawa R; Goto K; Muroyama R; Matsubara Y
Nihon Rinsho; 2015 Dec; 73 Suppl 9():262-8. PubMed ID: 26845942
[No Abstract] [Full Text] [Related]
2. Interferon-free strategies without a nucleoside/nucleotide analogue.
Welzel TM; Zeuzem S
Semin Liver Dis; 2014 Feb; 34(1):47-57. PubMed ID: 24782258
[TBL] [Abstract][Full Text] [Related]
3. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus].
Suda G; Yamasaki K; Sakamoto N
Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928
[No Abstract] [Full Text] [Related]
4. Genetic barrier and variant fitness in hepatitis C as critical parameters for drug resistance development.
Welsch C
Drug Discov Today Technol; 2014 Mar; 11():19-25. PubMed ID: 24847649
[TBL] [Abstract][Full Text] [Related]
5. Virology: fresh assault on hepatitis C.
Rice CM
Nature; 2003 Nov; 426(6963):129-31. PubMed ID: 14578912
[No Abstract] [Full Text] [Related]
6. Clinical relevance of HCV antiviral drug resistance.
Welsch C; Zeuzem S
Curr Opin Virol; 2012 Oct; 2(5):651-5. PubMed ID: 23006585
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of interferon resistance in hepatitis C.
Gretch D
Lancet; 2001 Nov; 358(9294):1662-4. PubMed ID: 11728538
[No Abstract] [Full Text] [Related]
8. Antiviral resistance and direct-acting antiviral agents for HCV.
Aloia AL; Locarnini S; Beard MR
Antivir Ther; 2012; 17(6 Pt B):1147-62. PubMed ID: 23188771
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic prospects in HCV treatment.
Almasio PL; Ingrassia D; Vergara B; Filosto S
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):775-9. PubMed ID: 19053890
[No Abstract] [Full Text] [Related]
10. HCV drug resistance and DAA agents.
Szymanek A; Krzysztof S
Przegl Epidemiol; 2013; 67(3):403-6, 513-5. PubMed ID: 24340550
[TBL] [Abstract][Full Text] [Related]
11. Impact of new hepatitis C treatments in different regions of the world.
Wei L; Lok AS
Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
[No Abstract] [Full Text] [Related]
12. Changing the face of hepatitis C management - the design and development of sofosbuvir.
Noell BC; Besur SV; deLemos AS
Drug Des Devel Ther; 2015; 9():2367-74. PubMed ID: 25987834
[TBL] [Abstract][Full Text] [Related]
13. Interview with Celia Schiffer.
Schiffer C
Future Med Chem; 2013 Jul; 5(11):1193-7. PubMed ID: 23859201
[No Abstract] [Full Text] [Related]
14. Excitement grows for potential revolution in hepatitis C virus treatment.
Opar A
Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
[No Abstract] [Full Text] [Related]
15. [How to treat non-responders to antiviral bitherapy for hepatitis C?].
Guyader D
Gastroenterol Clin Biol; 2007 Mar; 31(3):317-24. PubMed ID: 17396096
[No Abstract] [Full Text] [Related]
16. A review of HCV protease inhibitors.
Chen KX; Njoroge FG
Curr Opin Investig Drugs; 2009 Aug; 10(8):821-37. PubMed ID: 19649927
[TBL] [Abstract][Full Text] [Related]
17. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
Sarrazin C; Zeuzem S
Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
[TBL] [Abstract][Full Text] [Related]
18. Update on alisporivir in treatment of viral hepatitis C.
Flisiak R; Jaroszewicz J; Flisiak I; Łapiński T
Expert Opin Investig Drugs; 2012 Mar; 21(3):375-82. PubMed ID: 22316207
[TBL] [Abstract][Full Text] [Related]
19. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Kwong AD; Najera I; Bechtel J; Bowden S; Fitzgibbon J; Harrington P; Kempf D; Kieffer TL; Koletzki D; Kukolj G; Lim S; Pilot-Matias T; Lin K; Mani N; Mo H; O'Rear J; Otto M; Parkin N; Pawlotsky JM; Petropoulos C; Picchio G; Ralston R; Reeves JD; Schooley RT; Seiwert S; Standring D; Stuyver L; Sullivan J; Miller V; ; ; ;
Gastroenterology; 2011 Mar; 140(3):755-60. PubMed ID: 21255574
[No Abstract] [Full Text] [Related]
20. Advances in and the future of treatments for hepatitis C.
Cheng R; Tu T; Shackel N; McCaughan GW
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):633-47. PubMed ID: 24846594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
